Presentation is loading. Please wait.

Presentation is loading. Please wait.

The SmartTarget Biopsy Trial: A Prospective, Within-person Randomised, Blinded Trial Comparing the Accuracy of Visual-registration and Magnetic Resonance.

Published by营 宣 Modified over 5 years ago

Similar presentations

Presentation on theme: "The SmartTarget Biopsy Trial: A Prospective, Within-person Randomised, Blinded Trial Comparing the Accuracy of Visual-registration and Magnetic Resonance."— Presentation transcript:

1 The SmartTarget Biopsy Trial: A Prospective, Within-person Randomised, Blinded Trial Comparing the Accuracy of Visual-registration and Magnetic Resonance Imaging/Ultrasound Image-fusion Targeted Biopsies for Prostate Cancer Risk Stratification  Sami Hamid, Ian A. Donaldson, Yipeng Hu, Rachael Rodell, Barbara Villarini, Ester Bonmati, Pamela Tranter, Shonit Punwani, Harbir S. Sidhu, Sarah Willis, Jan van der Meulen, David Hawkes, Neil McCartan, Ingrid Potyka, Norman R. Williams, Chris Brew-Graves, Alex Freeman, Caroline M. Moore, Dean Barratt, Mark Emberton, Hashim U. Ahmed  European Urology  DOI: /j.eururo Copyright © 2018 The Authors Terms and Conditions

2 Fig. 1 Disposition of patients.
European Urology DOI: ( /j.eururo ) Copyright © 2018 The Authors Terms and Conditions

Download ppt "The SmartTarget Biopsy Trial: A Prospective, Within-person Randomised, Blinded Trial Comparing the Accuracy of Visual-registration and Magnetic Resonance."

Similar presentations

Volume 62, Issue 4, Pages (October 2012)

Volume 62, Issue 4, Pages (October 2012)
Early Detection of Prostate Cancer in 2007

Early Detection of Prostate Cancer in 2007
The PSA Era is not Over for Prostate Cancer

The PSA Era is not Over for Prostate Cancer
Results of Targeted Biopsy in Men with Magnetic Resonance Imaging Lesions Classified Equivocal, Likely or Highly Likely to Be Clinically Significant Prostate.

Results of Targeted Biopsy in Men with Magnetic Resonance Imaging Lesions Classified Equivocal, Likely or Highly Likely to Be Clinically Significant Prostate.
Volume 71, Issue 6, Pages (June 2017)

Volume 71, Issue 6, Pages (June 2017)
Volume 69, Issue 3, Pages (March 2016)

Volume 69, Issue 3, Pages (March 2016)
Volume 57, Issue 1, Pages (January 2010)

Volume 57, Issue 1, Pages (January 2010)
Volume 50, Issue 1, Pages (July 2006)

Volume 50, Issue 1, Pages (July 2006)
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Volume 52, Issue 3, Pages (September 2007)

Volume 52, Issue 3, Pages (September 2007)
Volume 66, Issue 1, Pages (July 2014)

Volume 66, Issue 1, Pages (July 2014)
Testosterone Therapy in Men With Prostate Cancer

Testosterone Therapy in Men With Prostate Cancer
Volume 56, Issue 6, Pages (December 2009)

Volume 56, Issue 6, Pages (December 2009)
Volume 191, Issue 6, Pages (June 2014)

Volume 191, Issue 6, Pages (June 2014)
Volume 74, Issue 4, Pages (October 2018)

Volume 74, Issue 4, Pages (October 2018)
Volume 61, Issue 6, Pages (June 2012)

Volume 61, Issue 6, Pages (June 2012)
Volume 67, Issue 1, Pages (January 2015)

Volume 67, Issue 1, Pages (January 2015)
Volume 53, Issue 4, Pages (April 2008)

Volume 53, Issue 4, Pages (April 2008)
Volume 64, Issue 6, Pages (December 2013)

Volume 64, Issue 6, Pages (December 2013)
Volume 67, Issue 4, Pages (April 2015)

Volume 67, Issue 4, Pages (April 2015)

Similar presentations

Ads by Google